Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
Regeneron Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 1,407 institutions reported holding Regeneron Pharmaceuticals, Inc., 87.2% of its shares. Largest: Vanguard, BlackRock and State Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Regeneron Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 10.7M | 10.5% | −164K | Nov 16, 2026 |
| BlackRock | 8.85M | 8.7% | −264K | Nov 13, 2026 |
| State Street | 4.88M | 4.8% | +46,674 | Nov 12, 2026 |
| Dodge & Cox | 4.77M | 4.7% | −96,648 | Nov 13, 2026 |
| Invesco | 3.72M | 3.7% | −219K | Nov 12, 2026 |
| JPMorgan | 3.31M | 3.3% | −467K | Nov 12, 2026 |
| Franklin Templeton | 2.96M | 2.9% | +121K | Nov 12, 2026 |
| Geode Capital | 2.63M | 2.6% | +7,016 | Nov 6, 2026 |
| Nuveen | 1.96M | 1.9% | −63,934 | Nov 12, 2026 |
| Loomis Sayles & Co L P | 1.72M | 1.7% | −143K | Nov 12, 2026 |